Cargando…

Mutant p53(L194F) Harboring Luminal-A Breast Cancer Cells Are Refractory to Apoptosis and Cell Cycle Arrest in Response to Mortaparib(Plus), a Multimodal Small Molecule Inhibitor

SIMPLE SUMMARY: Tumor suppressor protein p53 is a master regulator that inhibits the process of oncogenesis by induction of cell senescence/cell cycle arrest/apoptosis during normal and stressed states of cells. It is functionally inactivated in the majority of cancers. Mortalin, a member of the Hsp...

Descripción completa

Detalles Bibliográficos
Autores principales:	Elwakeel, Ahmed, Sari, Anissa Nofita, Dhanjal, Jaspreet Kaur, Meidinna, Hazna Noor, Sundar, Durai, Kaul, Sunil C., Wadhwa, Renu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8234533/ https://www.ncbi.nlm.nih.gov/pubmed/34207240 http://dx.doi.org/10.3390/cancers13123043

Ejemplares similares

Computational and in vitro experimental analyses of the anti-COVID-19 potential of Mortaparib and Mortaparib(Plus)
por: Kumar, Vipul, et al.
Publicado: (2021)

Identification of a new member of Mortaparib class of inhibitors that target mortalin and PARP1
por: Meidinna, Hazna Noor, et al.
Publicado: (2022)

Identification and Characterization of Mortaparib(Plus)—A Novel Triazole Derivative That Targets Mortalin-p53 Interaction and Inhibits Cancer-Cell Proliferation by Wild-Type p53-Dependent and -Independent Mechanisms
por: Sari, Anissa Nofita, et al.
Publicado: (2021)

A Low Dose Combination of Withaferin A and Caffeic Acid Phenethyl Ester Possesses Anti-Metastatic Potential In Vitro: Molecular Targets and Mechanisms
por: Sari, Anissa Nofita, et al.
Publicado: (2022)

Comparative computational and experimental analyses of some natural small molecules to restore transcriptional activation function of p53 in cancer cells harbouring wild type and p53(Ser46) mutant
por: Shefrin, Seyad, et al.
Publicado: (2022)

Mortaparib, a novel dual inhibitor of mortalin and PARP1, is a potential drug candidate for ovarian and cervical cancers
por: Putri, Jayarani F., et al.
Publicado: (2019)

Wild type p53 function in p53(Y220C) mutant harboring cells by treatment with Ashwagandha derived anticancer withanolides: bioinformatics and experimental evidence
por: Sundar, Durai, et al.
Publicado: (2019)

Caffeic acid phenethyl ester (CAPE) confers wild type p53 function in p53(Y220C) mutant: bioinformatics and experimental evidence
por: Radhakrishnan, Navaneethan, et al.
Publicado: (2021)

Combination of Withaferin-A and CAPE Provides Superior Anticancer Potency: Bioinformatics and Experimental Evidence to Their Molecular Targets and Mechanism of Action
por: Sari, Anissa Nofita, et al.
Publicado: (2020)

Marine Carotenoid Fucoxanthin Possesses Anti-Metastasis Activity: Molecular Evidence
por: Garg, Sukant, et al.
Publicado: (2019)

Bioinformatics and Molecular Insights to Anti-Metastasis Activity of Triethylene Glycol Derivatives
por: Malik, Vidhi, et al.
Publicado: (2020)

Molecular Characterization and Enhancement of Anticancer Activity of Caffeic Acid Phenethyl Ester by γ Cyclodextrin
por: Wadhwa, Renu, et al.
Publicado: (2016)

Molecular mechanism of anti-SARS-CoV2 activity of Ashwagandha-derived withanolides
por: Dhanjal, Jaspreet Kaur, et al.
Publicado: (2021)

Phosphatidylserine Exposed Lipid Bilayer Models for Understanding Cancer Cell Selectivity of Natural Compounds: A Molecular Dynamics Simulation Study
por: Radhakrishnan, Navaneethan, et al.
Publicado: (2022)

Computational Insights into the Potential of Withaferin-A, Withanone and Caffeic Acid Phenethyl Ester for Treatment of Aberrant-EGFR Driven Lung Cancers
por: Malik, Vidhi, et al.
Publicado: (2021)

Potential of Withaferin-A, Withanone and Caffeic Acid Phenethyl ester as ATP-competitive inhibitors of BRAF: A bioinformatics study
por: Malik, Vidhi, et al.
Publicado: (2021)

Computational Identification of BCR-ABL Oncogenic Signaling as a Candidate Target of Withaferin A and Withanone
por: Malik, Vidhi, et al.
Publicado: (2022)

Mixed Inhibition of cPEPCK by Genistein, Using an Extended Binding Site Located Adjacent to Its Catalytic Cleft
por: Katiyar, Shashank Prakash, et al.
Publicado: (2015)

A theoretical investigation of DNA dynamics and desolvation kinetics for zinc finger proteinZif268
por: Dutta, Shayoni, et al.
Publicado: (2015)

Computational identification of novel natural inhibitors of glucagon receptor for checking type II diabetes mellitus
por: Grover, Sonam, et al.
Publicado: (2014)

Embelin inhibits TNF-α converting enzyme and cancer cell metastasis: molecular dynamics and experimental evidence
por: Dhanjal, Jaspreet Kaur, et al.
Publicado: (2014)

Novel Caffeic Acid Phenethyl Ester-Mortalin Antibody Nanoparticles Offer Enhanced Selective Cytotoxicity to Cancer Cells
por: Wang, Jia, et al.
Publicado: (2020)

2, 3-Dihydro-3β-methoxy Withaferin-A Lacks Anti-Metastasis Potency: Bioinformatics and Experimental Evidences
por: Chaudhary, Anupama, et al.
Publicado: (2019)

Soyasapogenol-A targets CARF and results in suppression of tumor growth and metastasis in p53 compromised cancer cells
por: Omar, Amr, et al.
Publicado: (2020)

Withaferin-A kills cancer cells with and without telomerase: chemical, computational and experimental evidences
por: Yu, Yue, et al.
Publicado: (2017)

Molecular interactions of Bcl-2 and Bcl-xL with mortalin: identification and functional characterization
por: Saxena, Nishant, et al.
Publicado: (2013)

Computational Structure-Based De Novo Design of Hypothetical Inhibitors against the Anti- Inflammatory Target COX-2
por: Dhanjal, Jaspreet Kaur, et al.
Publicado: (2015)

Ashwagandha Derived Withanone Targets TPX2-Aurora A Complex: Computational and Experimental Evidence to its Anticancer Activity
por: Grover, Abhinav, et al.
Publicado: (2012)

Genome-wide DNA methylation profiling integrated with gene expression profiling identifies PAX9 as a novel prognostic marker in chronic lymphocytic leukemia
por: Rani, Lata, et al.
Publicado: (2017)

Targeting Mortalin by Embelin Causes Activation of Tumor Suppressor p53 and Deactivation of Metastatic Signaling in Human Breast Cancer Cells
por: Nigam, Nupur, et al.
Publicado: (2015)

Molecular dynamics simulations and experimental studies reveal differential permeability of withaferin-A and withanone across the model cell membrane
por: Wadhwa, Renu, et al.
Publicado: (2021)

194. Carbapenem Resistance Gene Detection in Positive Blood Cultures Reveals Emergence of NDM-Harboring Organisms and Associated Morbidity and Mortality
por: Haghamad, Aya, et al.
Publicado: (2023)

Functional characterization of miR-708 microRNA in telomerase positive and negative human cancer cells
por: Kaul, Zeenia, et al.
Publicado: (2021)

Future plans of PS 194
por: Knudsen, H, et al.
Publicado: (1995)

Health Tract, No. 194: Memories
Publicado: (1865)

Subject Index to Volume 194
Publicado: (2006)

Direct mass measurements of $^{194}$Hg and $^{194}$Au : A new route to the neutrino mass determination?
por: Eliseev, S, et al.
Publicado: (2010)

On future activities of the PS194 Collaboration
por: Uggerhøj, Erik
Publicado: (1990)

Effect of monocular sensitivity on binocular summation of luminance-modulated flicker
por: Reena Durai, C. Vijay, et al.
Publicado: (2023)

Etude de la désintégration $^{194}$Au --> $^{194}$Pt (T$_{1/2}$ = 53.0 $^{\pm}$ 1.4 s)
por: Caillau, M, et al.
Publicado: (1974)

Cannot write session to /tmp/vufind_sessions/sess_96h4evsmmduho47rvnrnaevvkh